All Details
SLU-PP-332
SLU-PP-332 1VIAL X 5MG VIAL
SLU-PP-332
5 mg – Uses for Bodybuilders
SLU-PP-332
is not a peptide. It
is an experimental small molecule often called an "exercise
mimetic" because it activates estrogen-related receptors (ERRα, ERRβ,
and ERRγ), which regulate mitochondrial function, endurance, and fat
metabolism. Most evidence comes from animal studies; there are currently no
completed human clinical trials.
Potential
Uses for Bodybuilders
- 🔥 Support fat loss during cutting
phases
- 🏃 Improve endurance and work
capacity
- ⚡ Increase mitochondrial function and energy
production
- 📉 Enhance fat oxidation (burning
fat for fuel)
- ⚖️ Improve body recomposition
- 💪 May help preserve lean mass
while dieting (indirectly)
What
Research Shows
Animal
studies found:
- Increased endurance performance
- Greater fat utilization
- Weight and fat-mass reduction
without major dietary changes
- Activation of pathways normally
stimulated by endurance exercise
Dosage
There is no
medically established or validated human dosage for SLU-PP-332. Human
studies have not been completed, and reported doses online vary widely.
Research and
community discussions commonly mention:
- 1–5 mg per day as an experimental range
- Often divided into 2–3
administrations because of its short half-life
- Typical experimental cycles
discussed are 4–8 weeks
If You
Have a 5 mg Vial
- A 5 mg vial contains 5 mg
total compound.
- How long it lasts depends on the
experimental dose being used.
Possible
Side Effects
Because
human data are lacking, the full side-effect profile is unknown. Reported
concerns include:
- Headache
- Fatigue
- Gastrointestinal discomfort
- Unknown long-term cardiovascular
and metabolic effects
Important
Note
SLU-PP-332
is an experimental research compound and is listed as a prohibited
metabolic modulator for tested athletes. Its safety and effectiveness in humans
have not been established.
Summary: Bodybuilders are interested in
SLU-PP-332 mainly for fat loss, endurance enhancement, and metabolic support,
rather than direct muscle growth. The evidence is currently based on animal
research, and no validated human dosing protocol exists.
